Join Matindale-Hubbell Connected



Search Results (3449)

  
Documents on pharmaceuticals
 

View Page: 1  2  3  4  5  6  7  8  9  10  Next  >>
Show: results per page
Sort by:
Sponsored Results

HTMLNew Drugs Being Developed for Acute Myeloid Leukemia
Waters Kraus LLP;
Legal Alert/Article
August 7, 2015, previously published on August 5, 2015
Like other forms of leukemia, acute myeloid leukemia is caused by benzene exposure. Benzene exposure is not uncommon among workers in many industries, including those who work around gasoline and crude oil, which both contain benzene. The U.S. government estimates that Americans used 137 billion...

 

HTMLCanada's Federal Court of Appeal Upholds C$180 Million Judgment in Favour of Merck Against Apotex in a Landmark Patent Damages Ruling
Steven Mason, David Tait, Steven Tanner; McCarthy Tetrault LLP;
Legal Alert/Article
August 6, 2015, previously published on July 30, 2015
In a Judgment released July 23, 2015, the Federal Court of Appeal upheld the Federal Court’s award of more than C$180 million in damages and interest for Apotex’s infringement of Merck’s Canadian lovastatin patent. In this decision, the Federal Court of Appeal reversed the Trial...

 

HTMLNovartis Pharmaceuticals Canada Inc. v. Teva Canada Limited, 2015 FC 770
Adrian J. Howard, Beverley Moore, Chantal Saunders; Borden Ladner Gervais LLP;
Legal Alert/Article
July 14, 2015, previously published on July 07, 2015
Novartis has obtained an order prohibiting the Minister from providing an NOC to Teva for EXJADE®. At the hearing, the issues were narrowed by Teva who alleged the patent was invalid for inutility, obviousness and insufficiency.

 

HTMLAstrazeneca Canada Inc. v. Apotex Inc., 2015 FC 671
Adrian J. Howard, Beverley Moore, Chantal Saunders; Borden Ladner Gervais LLP;
Legal Alert/Article
July 14, 2015, previously published on July 07, 2015
The parties moved under Rule 397 to modify the terms of the judgment in the proceeding, previously reported as 2015 FC 322 and summarized in our newsletter the week of April 13, 2015.

 

HTMLMother Nature Axes 340B Hearing, But Written Testimony Survives
Mintz Levin Cohn Ferris Glovsky Popeo P.C.;
Legal Alert/Article
July 3, 2015, previously published on March 5, 2015
Mother Nature claimed another victim this week. The U.S. House of Representatives Energy and Commerce Subcommittee on Health was scheduled to hold a hearing on March 5, 2015 ¿ Examining the 340B Drug Pricing Program. But with another winter storm aimed at Washington, the hearing was...

 

HTMLXarelto Science Day Set By Court
Robinson Waters ODorisio P.C.;
Legal Alert/Article
July 3, 2015, previously published on June 19, 2015
Hundreds of Xarelto lawsuits filed in federal court have been transferred for pretrial procedures to the U.S. District Court in the Eastern District of Louisiana. These Xarelto lawsuits are now part of a Multi-District Litigation (MDL) established to handle the cases more efficiently by having one...

 

HTMLFDA Reports Results of Annual Crack Down on Illegal Internet Pharmacies
Mintz Levin Cohn Ferris Glovsky Popeo P.C.;
Legal Alert/Article
June 29, 2015, previously published on June 26, 2015
Last week, FDA announced that more than 1,050 websites had illegal drugs and devices seized or received warning letters as part of the Eighth Annual International Internet Week of Action (IIWA). IIWA is an international effort of law enforcement, customs, and regulatory bodies (including FDA, the...

 

HTMLPublic Statements Made by Pharmaceutical and Biotech Company Executives May Raise FDA's Hackles if They Do Not Meet Basic Requirements for Promotional Communications
Joanne S. Hawana; Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.;
Legal Alert/Article
June 26, 2015, previously published on June 23, 2015
For players in the highly regulated pharmaceutical and health care industries, it is common knowledge that manufacturers and distributors of FDA-regulated products are required to promote their products in compliance with the Federal Food, Drug, and Cosmetic Act (the Act) and FDA’s...

 

HTMLCalifornia Lawsuit Filed on Behalf Of 12 Injured by Xarelto
Waters Kraus LLP;
Legal Alert/Article
June 18, 2015, previously published on April 22, 2015
Bayer Corp. and Janssen Pharmaceuticals Inc. (a unit of Johnson & Johnson) have been sued in a California lawsuit by 12 people injured from using the companies’ blood thinner Xarelto. The plaintiffs who filed the California lawsuit were taking Xarelto to treat atrial fibrillation or to...

 

HTMLFederal Judge Makes Important Ruling in Xarelto Lawsuits
Waters Kraus LLP;
Legal Alert/Article
June 17, 2015, previously published on June 1, 2015
As the number of Xarelto lawsuits rises due to the drug’s link to uncontrollable bleeding in patients, cases filed in federal court have been assigned to a single judge in the Eastern District of Louisiana — Judge Eldon Fallon. In May 2015, Judge Fallon ordered lawyers in the Xarelto...

 


View Page: 1  2  3  4  5  6  7  8  9  10  Next  >>